Market Overview - Asian shares exhibited mixed performance amid thin holiday trading, with most markets closed for Christmas. The Nikkei 225 in Tokyo increased by 0.1% to 50,407.79, marking a nearly 30% gain for the year [1] - The Shanghai Composite index in mainland China rose by 0.5% to 3,959.62, while Hong Kong's exchange was closed [1] Central Bank Actions - The People's Bank of China (PBOC) reassured investors by committing to ensure adequate money supply to support financing, economic growth, and inflation targets. The PBOC maintained its key short-term lending rates earlier in the week [2] US Market Performance - The S&P 500 index increased by 0.3% to 6,932.05, while the Dow Jones Industrial Average rose by 0.6% to 48,731.16, and the Nasdaq composite added 0.2% to 23,613.31 [3] - The S&P 500 has gained over 17% this year, driven by investor optimism regarding the Trump administration's deregulatory policies and the potential of artificial intelligence to enhance profits across various sectors [5] Economic Indicators - The US economy experienced a robust growth rate of 4.3% annually in Q3, the fastest in two years, primarily fueled by consumer spending despite high inflation [7] - Jobless claims in the US decreased by 10,000 to 214,000 for the week ending December 20, remaining below the forecast of 232,000 new applications, indicating a still healthy labor market [8] Company News - Dynavax Technologies' shares surged by 38.2% following Sanofi's announcement of acquiring the company for $2.2 billion, which will enhance Sanofi's vaccine portfolio [9] - Novo Nordisk's shares rose by 1.8% after receiving US regulatory approval for a pill version of its weight loss drug Wegovy, although the company’s shares are down nearly 40% this year due to increased competition from Eli Lilly, whose shares have increased by 40% this year [10]

Market Overview - Wall Street remained largely unchanged with the Dow Jones Industrial Average up 0.1%, S&P 500 index up less than 0.1%, and Nasdaq Composite down 0.1% as of early Wednesday [1] - Markets will close early at 1 p.m. ET for Christmas Eve and will be closed for Christmas, with a full trading day on Friday expected but with light volumes due to the holiday [2] Economic Indicators - Recent reports indicate high inflation and declining consumer confidence, with concerns over high prices affecting the labor market and retail sales [3] - U.S. applications for jobless claims fell by 10,000 to 214,000 for the week ending Dec. 20, which is below the forecast of 232,000 new applications [4] Company News - Dynavax Technologies' stock surged 38% following Sanofi's announcement of its acquisition for $2.2 billion, which will enhance Sanofi's portfolio with Dynavax's hepatitis B vaccines and a shingles vaccine in development [5] Commodity Market - Both gold and silver futures experienced increases, with silver prices rising over 1%, while U.S. crude oil prices rose 0.4% to $58.61 per barrel [6]

Market Performance - Wall Street closed higher with the S&P 500 index rising 22.26 points, or 0.3%, to 6,932.05, the Dow Jones Industrial Average increasing by 288.75 points, or 0.6%, to 48,731.16, and the Nasdaq composite adding 51.46 points, or 0.2%, to 23,613.31 on a holiday-shortened trading day [1] - Trading volume was light, with approximately 1.8 billion shares traded on the New York Stock Exchange, about one-third of the average trading day [1][2] Economic Indicators - The U.S. economy grew at a surprising annual rate of 4.3% in the third quarter, marking the fastest expansion in two years, driven by consumer spending despite ongoing inflation [5] - Jobless claims fell by 10,000 to 214,000 for the week ending Dec. 20, remaining below the forecast of 232,000 new applications, indicating a still healthy labor market despite signs of weakening [6] Company Developments - Dynavax Technologies' shares surged 38.2% following Sanofi's announcement of acquiring the company for $2.2 billion, which will enhance Sanofi's portfolio with Dynavax's hepatitis B vaccines and a shingles vaccine in development [7] - Novo Nordisk's shares increased by 1.8% after receiving U.S. regulatory approval for a pill version of its weight-loss drug Wegovy, although the company’s shares are down nearly 40% this year due to increased competition from Eli Lilly, whose shares have risen by 40% this year [8] Investor Sentiment - Investors are optimistic about the future of artificial intelligence and its potential to boost profits across various sectors, contributing to a more than 17% increase in the S&P 500 this year [3] - The focus for investors in the coming weeks will be on the direction of the U.S. economy and the Federal Reserve's interest rate decisions, with expectations that the Fed will maintain current rates in January [4]

Public Health & Policy Concerns - The hearing focuses on potential pressure to pursue anti-vaccine policies and defy scientific evidence, which could significantly impact public health [3] - Concerns exist regarding the Secretary of Health and Human Services potentially directing the approval of vaccines without scientific evidence and dismissing career officials responsible for vaccine policy [7][8] - The Secretary of Health and Human Services is accused of wanting data to support the claim that measles vaccine causes blindness and deafness, despite evidence to the contrary [11] - There are worries that the advisory committee on immunization practices will revisit critical vaccines for kids, potentially overstating risks, understating benefits, and cherry-picking evidence [13] - The vaccine committee has been replaced with known critics of vaccines and operates under decreased transparency with a willful refusal to follow established scientific and decision-making procedures [23] Political Implications - Senator Cassidy, who called for the hearing, faces a primary challenge and concerns that he might be stirring up controversy [4][5] - Senator Cassidy previously insisted that the Secretary of Health and Human Services not change ACIP recommendations or the way ACIP is constructed, but these agreements may have been violated [17] - There is a call for Senator Cassidy to gather other Republican senators to address the President regarding the Secretary of Health and Human Services' stance on vaccines [20] Vaccine Advisory Meeting - A key advisory board meeting on vaccine panels is approaching, making the hearing even more significant [4] - The advisory committee on immunization practices will be meeting and there's a lot of efforts to prebunk what we expect is going to happen there, which is a significant revisiting of critical vaccines for kids [13] - Senator Cassidy has called for that vaccine meeting the advisory meeting to be put on hold indefinitely because or if they meet for people not to follow their guidance [15]